Company · APVO · CIK 1671584

Aptevo Therapeutics Inc. (APVO) SEC filings and CIK.

APVO’s SEC Central Index Key (CIK) is 0001671584, or 1671584 without leading zeros. The SEC’s ticker file lists it as Aptevo Therapeutics Inc..

Ticker
APVO
CIK
0001671584
Other tickers
None
Insider transactions, Q3 2026
13

Insider trading

In Q3 2026, insiders at Aptevo Therapeutics Inc. reported 13 non-derivative transactions on 10 Forms 3, 4 and 5, including 0 open-market purchases and 0 sales. See every APVO insider transaction →

Recent filings we observed

From our record of EDGAR’s latest-filings feed and sampled daily indexes. Not a complete filing history; use the filings API for that.
FiledFormAccession
2026-11-098-K0001193125-26-452737

Form D offerings

FiledTypeAmount soldIndustry
2026-08-26D$3.5MPharmaceuticals

Get APVO SEC data through the API

Filing history
curl "https://sec-api.dev/api/v1/filings?cik=1671584&limit=10" \
  -H "Authorization: Bearer $SEC_API_KEY"
Company profile
curl "https://sec-api.dev/api/v1/companies/1671584" \
  -H "Authorization: Bearer $SEC_API_KEY"
Reported XBRL facts
curl "https://sec-api.dev/api/v1/facts/1671584?taxonomy=us-gaap&concept=Revenues&limit=10" \
  -H "Authorization: Bearer $SEC_API_KEY"

Ticker to CIK API · SEC filings API · Aptevo Therapeutics Inc. on SEC.gov

Questions

What is APVO’s CIK number?

APVO’s SEC Central Index Key (CIK) is 0001671584, or 1671584 without leading zeros. The SEC’s ticker file lists it as Aptevo Therapeutics Inc..

How do I find Aptevo Therapeutics Inc.’s 10-K?

Request /api/v1/filings?cik=1671584&form=10-K, or open the company’s EDGAR page and filter by 10-K. Foreign issuers file 20-F or 40-F instead.

Ticker and CIK: SEC company_tickers.json, cached 2026-11-02. Tickers can move between entities; the CIK identifies the filer.

Plain-text version for agents and LLMs: /companies/apvo.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.